1. Home
  2. BGSF vs CSBR Comparison

BGSF vs CSBR Comparison

Compare BGSF & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

N/A

Current Price

$3.88

Market Cap

64.0M

ML Signal

N/A

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$4.59

Market Cap

65.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGSF
CSBR
Founded
2007
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.0M
65.4M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
BGSF
CSBR
Price
$3.88
$4.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 12.2K
6.8K
Earning Date
11-04-2026
12-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $93,310,000.00
$2,900,000.00
Revenue This Year
$2.61
$9.83
Revenue Next Year
N/A
$8.50
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.23
$4.40
52 Week High
$6.75
$8.31

Technical Indicators

Market Signals
Indicator
BGSF
CSBR
Relative Strength Index (RSI) 39.35 28.74
Support Level $3.23 N/A
Resistance Level $5.83 $6.29
Average True Range (ATR) 0.32 0.12
MACD 0.01 -0.04
Stochastic Oscillator 38.62 0.00

Price Performance

Historical Comparison
BGSF
CSBR

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. The company operates in one segment of Property Management, which includes centralized support services through executive, marketing, human resources, information technology, accounting, treasury, and billing operations.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Share on Social Networks: